HNF 1 alpha mutated hepatic adenoma

HNF 1 alpha mutated hepatic adenomas are a genetic and pathologic subtype of hepatic adenoma. Their appearance and prognosis are different from other subtypes.

They are the second most common (30-35%) hepatic adenoma, after the inflammatory subtype. They occur only in female patients, most with a history of oral contraceptive (OCP) use.

May develop right upper quadrant pain from intratumoral hemorrhage.

This subtype of adenoma is multiple in ~50%.

  • T1: isointense or  hyperintense relative to liver
  • T1 C+ (Gd):
    • moderate arterial phase enhancement (less than inflammatory subtype)
    • less likely to have persistent enhancement on portal venous and delayed phases, cf. inflammatory subtype
  • IP/OP: hypointensity on the out-of-phase sequence
  • T2: isointense to mildly hyperintense

If imaging shows a hepatic adenoma, then patients usually stop OCPs and the lesions regresses.

If it does not regress, then one treatment pathway suggests:

  • ≥5 cm: resection (hepatic adenomas larger than 5 cm are at increased risk of hemorrhage)
  • <5 cm: biopsy

Tissue diagnosis then confirms or changes the adenoma subtype. If HNF 1 alpha mutated pathologic subtype, then:

  • clinical and imaging follow up of any remaining adenomas until menopause
  • resection or thermal ablation of enlarging adenomas that grow >5 cm
  • genetic counseling if there is hepatic adenomatosis, familial history of hepatic adenoma, or MODY3 (mature onset diabetes of the young, type 3)

There is also a very small risk that a hepatic adenoma may develop into a hepatocellular carcinoma (HCC).

Hepatobiliary pathology
Share article

Article information

rID: 35198
Synonyms or Alternate Spellings:
  • HNF 1alpha mutated hepatic adenomas
  • HNF 1alpha mutated hepatic adenomata

Support Radiopaedia and see fewer ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.